Biofil Chemicals and Pharmaceuticals Limited has intimated the National Stock Exchange of India Limited and BSE Limited about a scheduled meeting of its Board of Directors.
The meeting is scheduled to be held on Saturday, 14th November, 2026 at the Registered Office of the Company located at B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.).
Agenda Items
1. To consider and approve the Un-Audited Financial Results of the Company for the Quarter and Half year ended on 30th September, 2026 along with Limited Review Report thereon.
2. To consider other routine matters with the permission of the chair.
Trading Window Update
In continuation of the earlier disclosure dated 24th September, 2026, and pursuant to the Company's Code of Conduct framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Un-Audited Financial Results for the quarter and Half year ended 30th September, 2026. This applies to all designated persons, their immediate relatives, and all connected persons covered under the code.